Navigenics
Foster City
About Navigenics
Navigenics, Inc. helps educate and empower individuals and their physicians with knowledge of their genetic predispositions, and then motivates them to act on the information to prevent the onset of disease, achieve earlier diagnosis, appropriately manage disease, or otherwise lessen its impact. Navigenics' lead investors are Kleiner Perkins Caufield and Byers, Sequoia Capital and MDV-Mohr Davidow Ventures.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $43.0M
- Funding stage: M&A
- Last round: Series C (Feb 2010)
- Website: navigenics.com
- Phone: (800)917-6090
Industries & Categories
Biotechnology, Genetics, Health Care, Pet
Social Profiles
Canonical: https://fsome.com/organization/navigenics-3289307 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.